GlobalData
GlobalData

Medical Devices

GeneCentric’s funding highlights growing investor interest in RNA-driven diagnostics in precision oncology, says GlobalData

GeneCentric Therapeutics has recently secured $8 million in new funding to advance its RNA-based liquid biopsy platform. The financing will support the development and commercialization of GeneCentric’s platform, which enables non-invasive tumor profiling to guide treatment decisions and monitor disease progression. The funding reflects the growing investor enthusiasm for RNA-driven diagnostics in precision oncology, according […]
Read more

Japan diagnostic imaging market poised for 2% CAGR through 2034, forecasts GlobalData

Japan’s diagnostic imaging sector is undergoing significant transformation, with cutting-edge technologies that are re-defining capabilities across techniques such as CT, MRI, ultrasound, and breast imaging. Against this backdrop, the country’s diagnostic imaging market is projected to expand at a compound annual growth rate (CAGR) of 2% through 2034, forecasts GlobalData, a leading data and analytics […]
Read more

US HPV testing market shielded from tariffs but export risks for domestic makers remain, reveals GlobalData

The US human papillomavirus (HPV) testing market will remain unaffected by the Trump Administration’s tariffs, as the leading tests—Roche’s cobas and Hologic’s Aptima Panther—are entirely manufactured within the country. With 94.6% of HPV tests produced within the country, the risk of cost increases or supply chain disruptions is minimal. However, export challenges may arise for […]
Read more

US cardiovascular device market under threat from tariffs, says GlobalData

US medical device companies continue to face uncertainty and instability as President Donald Trump’s tariffs continue to disrupt the market. Major manufacturers are currently most concerned with supply chain interruptions and cost increases, leading to constant adjustments of company forecasts. Cardiovascular devices are especially vulnerable to the impacts of tariffs, as many of these devices […]
Read more

Abbott and Medtronic best positioned manufacturers in US neurology market, says GlobalData

As US tariff policies evolve in 2025, neurology device manufacturers face rising cost pressures and growing uncertainty over production strategy. However, Abbott and Medtronic are best positioned among top competitors, with majority of their 510(k)-approved neurology devices manufactured exclusively in the US, respectively, according to the MedSource Database of GlobalData, a leading data and analytics […]
Read more

GlobalData highlights impact of US tariffs on medical robotics industry

The US government’s imposition of new tariffs in 2025 marks a significant shift in trade policy that has wide-reaching implications across multiple sectors, including healthcare. Among the most affected segments is the medical robotics industry, a high-growth field that blends precision engineering, artificial intelligence (AI), and life-saving applications in surgery and diagnostics. While tariffs are […]
Read more

Pulsed field ablation devices face growth challenges as US tariffs disrupt cardiovascular market, says GlobalData

The US cardiovascular devices market is facing growing challenges as President Trump’s tariffs disrupt global supply chains and worsen international relations. Particularly, pulsed field ablation (PFA) devices, often manufactured abroad for cost, efficiency, and material access, are now subject to higher tariffs. This disruption could slow the significant growth seen in the sector in recent […]
Read more

Mammography equipment market in South Korea to grow at 4% CAGR through 2036, forecasts GlobalData

The market for mammography equipment in South Korea is undergoing significant growth. This upsurge is attributable to the broadening scope of breast cancer screening initiatives, increased public awareness, and the incorporation of sophisticated imaging technologies. Owing to these factors, the mammography equipment market in South Korea is set to grow at a compound annual growth […]
Read more

US structural heart occlusion market sees early 2025 growth amid trade uncertainty, says GlobalData

The US Structural Heart Occlusion (SHO) market posted a notable 39% year-over-year revenue increase in Q1 2025, amid heightened trade policy uncertainty following President Donald Trump’s re-election and the swift introduction of new tariff measures in early 2025, according to GlobalData, a leading data and analytics company. Trump’s new tariff regime includes a 10% global […]
Read more

Mycobacterium tuberculosis tests market in Japan to grow at 4% CAGR through 2036, forecasts GlobalData

As one of the world’s deadliest infectious diseases, tuberculosis (TB) continues to pose a significant global health challenge, especially in low-resource settings, where the lack of timely, accurate, and accessible diagnostics hampers eradication efforts. Against this backdrop, the Mycobacterium tuberculosis tests market in Japan is projected to achieve substantial growth, with an anticipated compound annual […]
Read more

US medical device companies show diverging paths on tariff strategy, says GlobalData

The Trump administration’s 2025 trade agenda is compelling US medical device companies to address escalating tariff pressures, especially those on imports from China. While some are making decisive shifts in their manufacturing strategies, others are conservatively absorbing short-term impacts and awaiting tariff stabilization. As such, firms must carefully evaluate the long-term risks of trade disruption […]
Read more
1 4 5 6 7 8 51